Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Trading Statement

27 Sep 2017 07:00

RNS Number : 8921R
Halma PLC
27 September 2017
 

Halma plc

 

Trading Update

 

27 September 2017

 

Trading Update

 

Halma, the leading safety, health and environmental technology group today releases its scheduled Trading Update, relating to trading for the period from 2 April 2017.

 

Halma made good progress in line with the Board's expectations. The improved rates of organic constant currency revenue and profit growth achieved in the second half of the last financial year have continued into the current year. Order intake was ahead of revenue and also ahead of the same period last year.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. Asia Pacific maintained strong growth, with good progress in the UK and Mainland Europe and a steady performance in the USA.

 

The Environmental & Analysis sector performed particularly well, benefitting from strong growth in Asia Pacific and the re-organisation in its Life Science and Research business during the first half of last year.

 

The improved performance achieved by the Process Safety sector in the second half of last year continued. Market diversification and rising demand from the US onshore energy market both contributed to significant growth over the prior year.

 

The Infrastructure Safety sector continued to achieve good growth as greater investment in new product development in recent years contributed towards increasing demand from Asia Pacific and Mainland Europe.

 

The Medical sector also achieved solid revenue growth, although profitability was lower due to increased investment in new product development and sales resources.

 

In August 2017, we announced the acquisitions of Cardios for an initial consideration of R$50m (£12.1m) and CASMED for $4.5m (£3.4m). Both businesses strengthen our Medical sector's blood pressure monitoring technology base, with Cardios also being Halma's first acquisition in Brazil. The integration of both businesses is progressing well.

 

Our M&A pipeline strengthened during the period. We continue to search for businesses in, or adjacent to, all four sectors and the additional sector resources added during 2016 have improved both the quantity and quality of our opportunities.

 

Cash generation was good and the Group's financial position remains strong.

 

The results for the half year ending 30 September 2017 will be released on 21 November 2017.

 

 

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDCUDDBGRL
Date   Source Headline
1st Apr 20083:34 pmRNSTotal Voting Rights
28th Mar 20084:04 pmRNSTreasury Stock
27th Mar 20089:47 amRNSHolding(s) in Company
25th Mar 20086:07 pmRNSDirector/PDMR Shareholding
14th Mar 200811:42 amRNSDirector/PDMR Shareholding
3rd Mar 20084:19 pmRNSTotal Voting Rights
29th Feb 20084:40 pmRNSHolding(s) in Company
19th Feb 20082:46 pmRNSHolding(s) in Company
18th Feb 200811:45 amRNSHolding(s) in Company
18th Feb 20089:59 amRNSTreasury Stock
14th Feb 20087:00 amRNSInterim Management Statement
5th Feb 20081:08 pmRNSHolding(s) in Company
1st Feb 20083:17 pmRNSBlocklisting Interim Review
1st Feb 20083:15 pmRNSTotal Voting Rights
9th Jan 20083:59 pmRNSTreasury Stock
8th Jan 200811:12 amRNSHolding(s) in Company
4th Jan 20081:06 pmRNSHolding(s) in Company
2nd Jan 20084:47 pmRNSTotal Voting Rights
21st Dec 200711:25 amRNSDirector Declaration
20th Dec 20077:00 amRNSAcquisition
4th Dec 20073:09 pmRNSDirector/PDMR Shareholding
4th Dec 200711:50 amRNSTotal Voting Rights
29th Nov 200711:23 amRNSDoc re. Half year report 2007
29th Nov 20077:00 amRNSInterim Results
16th Nov 20074:18 pmRNSNotice of Results
6th Nov 20071:03 pmRNSHolding(s) in Company
2nd Nov 200711:48 amRNSTotal Voting Rights
25th Oct 20077:00 amRNSPost-Close Trading Update
5th Oct 20074:02 pmRNSTreasury Stock
1st Oct 200710:00 amRNSTotal Voting Rights
27th Sep 200710:22 amRNSTreasury Stock
19th Sep 20079:38 amRNSDirector/PDMR Shareholding
3rd Sep 20073:08 pmRNSTotal Voting Rights
7th Aug 20075:35 pmRNSTreasury Stock
3rd Aug 20075:33 pmRNSDoc re. AGM 2007 Resolutions
3rd Aug 20074:15 pmRNSHolding(s) in Company
2nd Aug 200711:34 amRNSDirectorate Change
1st Aug 20077:00 amRNSInterim Management Statement
31st Jul 200710:22 amRNSTotal Voting Rights
30th Jul 200712:40 pmRNSHolding(s) in Company
27th Jul 20074:46 pmRNSHolding(s) in Company
26th Jul 200711:36 amRNSAnnual Information Update
20th Jul 200712:39 pmRNSBlocklisting Interim Review
11th Jul 20073:13 pmRNSHolding(s) in Company
10th Jul 20072:15 pmRNSHolding(s) in Company
9th Jul 200712:07 pmRNSDirector/PDMR Shareholding
3rd Jul 20072:53 pmRNSDirector/PDMR Shareholding
29th Jun 200711:57 amRNSTotal Voting Rights
27th Jun 20072:50 pmRNSDirector/PDMR Shareholding
27th Jun 20079:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.